Variant report
Variant | nsv880779 |
---|---|
Chromosome Location | chr5:12465904-12525748 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:12474403..12476609-chr5:12481266..12483137,2 | MCF-7 | breast: | |
2 | chr5:12474403..12476609-chr5:12481266..12483137,2 | MCF-7 | breast: | |
3 | chr5:12474522..12476679-chr5:12488826..12490778,2 | MCF-7 | breast: | |
4 | chr5:12474522..12476679-chr5:12488826..12490778,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs56412428 | chr5:12465904-12465905 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs527729833 | chr5:12465936-12465937 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs546051725 | chr5:12466004-12466005 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs138380264 | chr5:12466043-12466044 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs185904165 | chr5:12466067-12466068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs191812482 | chr5:12466073-12466074 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs143971610 | chr5:12466080-12466081 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs561466813 | chr5:12466100-12466101 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs183224399 | chr5:12466122-12466123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs576098988 | chr5:12466123-12466124 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs531383030 | chr5:12466125-12466126 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs186430428 | chr5:12466131-12466132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs73744664 | chr5:12466143-12466144 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs529553979 | chr5:12466153-12466154 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs541731399 | chr5:12466156-12466157 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs41081 | chr5:12466185-12466186 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs72728930 | chr5:12466221-12466222 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs191036533 | chr5:12466249-12466250 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs538499909 | chr5:12466270-12466271 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs531031496 | chr5:12466280-12466281 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs182363653 | chr5:12466335-12466336 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs547334312 | chr5:12466371-12466372 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs114253449 | chr5:12466402-12466403 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs553620033 | chr5:12466430-12466431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs143062335 | chr5:12466457-12466458 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs186600051 | chr5:12466463-12466464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs115045613 | chr5:12466489-12466490 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs143415239 | chr5:12466493-12466494 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs42282 | chr5:12466561-12466562 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs376393938 | chr5:12466568-12466569 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs192540695 | chr5:12466593-12466594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs576062020 | chr5:12466620-12466621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs183336851 | chr5:12466718-12466719 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs369950953 | chr5:12466719-12466720 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs113623787 | chr5:12466753-12466754 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs188561811 | chr5:12466754-12466755 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs578204367 | chr5:12466783-12466784 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs545424468 | chr5:12466793-12466794 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs11133716 | chr5:12466798-12466799 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs376845498 | chr5:12466847-12466848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs148372740 | chr5:12466877-12466878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs141429829 | chr5:12466903-12466904 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs561066306 | chr5:12466945-12466946 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs75678581 | chr5:12466947-12466948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs547196167 | chr5:12466952-12466953 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs370605176 | chr5:12466962-12466963 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs32249 | chr5:12466975-12466976 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs539720479 | chr5:12466989-12466990 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs80354386 | chr5:12466995-12466996 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs150817865 | chr5:12466996-12466997 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cervical squamous cell carcinoma | 21590768 | CNVD |
abnormal development | 18461090 | CNVD |
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Autism | 22495311 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Intellectual disability | 22102821 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cri-du chat syndrome | 16773131 | CNVD |
Cryptorchidism | 21048976 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Cervical cancer | 16585170 | CNVD |
Mental retardation | 16773131 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Cri-du chat syndrome | 22470819 | CNVD |
sporadic birth defects | 19047251 | CNVD |
Non-small cell lung cancer | 17643093 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Schizophrenia | 18940311 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Mental retardation | 17847001 | CNVD |
Neurocytoma | 17123091 | CNVD |
Mental retardation | 19546859 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Glioma | 20126413 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:12462000-12469200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr5:12488200-12488400 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
3 | chr5:12488200-12488600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr5:12501600-12505600 | Weak transcription | H9 Cell Line | embryonic stem cell |
5 | chr5:12503400-12504600 | ZNF genes & repeats | ES-I3 Cell Line | embryonic stem cell |
6 | chr5:12504000-12505000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
7 | chr5:12504200-12505000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
8 | chr5:12504200-12507000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
9 | chr5:12504400-12506200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
10 | chr5:12504600-12505000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
11 | chr5:12504600-12507400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
12 | chr5:12505000-12505200 | Flanking Active TSS | iPS-18 Cell Line | embryonic stem cell |
13 | chr5:12505000-12505200 | Flanking Active TSS | iPS-20b Cell Line | embryonic stem cell |
14 | chr5:12505000-12506000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
15 | chr5:12505200-12505400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
16 | chr5:12505200-12505400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
17 | chr5:12505400-12505600 | Flanking Active TSS | iPS-20b Cell Line | embryonic stem cell |
18 | chr5:12505400-12505800 | Flanking Active TSS | iPS-18 Cell Line | embryonic stem cell |
19 | chr5:12505600-12505800 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
20 | chr5:12505600-12506400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
21 | chr5:12505800-12506000 | Enhancers | H9 Cell Line | embryonic stem cell |
22 | chr5:12505800-12506400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
23 | chr5:12507200-12507400 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
24 | chr5:12507600-12522400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
25 | chr5:12509800-12511800 | Weak transcription | H1 Cell Line | embryonic stem cell |